Lin Chan represents consumers, small businesses, and employees in class actions involving antitrust, fraud, discrimination, and wage theft. Lin has represented California consumers and third party payors of Cipro in a class action charging that brand name and generic prescription drug manufacturers conspired to restrain competition in the sale of Bayer’s blockbuster antibiotic drug Cipro. Total settlements in the case reached $399 million. Lin has also represented consumers in a class action filed against lithium ion battery manufacturers for conspiring to fix the prices of lithium ion batteries, as well as direct purchasers of titanium dioxide against titanium dioxide manufacturers for conspiring to fix prices. In 2017, Lin won the prestigious award for “Outstanding Antitrust Achievement by a Young Lawyer” from the American Antitrust Institute for her work on the Cipro drug antitrust cases, as well as sharing Lieff Cabraser’s team award from the AAI for “Outstanding Private Practice Antitrust Achievement” for their work on the Cipro case. Lin chairs the Antitrust and Business Regulation Section of the Bar Association of San Francisco and serves as Secretary of the Committee to Support the Antitrust Laws. She previously served as a law clerk to the Honorable Damon J. Keith of the Sixth Circuit U.S. Court of Appeals from 2007 to 2008. While at Stanford, Lin was the Editor-in-Chief of the Stanford Journal of Civil Rights and Civil Liberties.
